CTRI/2021/01/030359尚未招募未知
Complete estrogen blockade in recalcitrant mastalgia:A randomized clinical trial.
All India Institute of Medical Sciences Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Women giving consent with recalcitrant mastalgia, normal menstrual cycles,
- •non pregnant,
- •no personal history of breast or ovarian cancer.
排除标准
- •Cancer breast/ovary,
- •Pregnancy, breast feeding or lady desiring pregnancy in next 6 months, Lady with PCOD or cervical hyperplasia, Lady not giving consent
研究者
相似试验
已完成
不适用
Treatment of non-responsive breast pain.CTRI/2017/12/010745Intra mural research grant10
已完成
不适用
Hormonal therapy resistant estorgen receptor positive metastatic breast cancer cohort studyBreast cancerJPRN-UMIN000019556General Incorporated Association of CSPOR-BC200
进行中（未招募）
1 期
Vaginal administration of selective estrogen receptor modulator (Tamoxifen) treatment to improve sexual function for women with breast cancer. A randomized, double-blinded, placebo controlled longitudinal phase 3 study.Most troublesome vulvovaginal atrophy symptomEUCTR2021-004536-28-SEppsala University, Department of Women's and Children´s Health120
已完成
3 期
Evaluation of estrogen therapy on the height of children with chronic kidney diseaseIRCT20201110049334N1Iran University of Medical Sciences75
已完成
不适用
Clinical Trial of a Selective Estrogen Receptor Modulator (raloxifene) in Schizophreniacognitive deficits in patients with schizophreniapsychotic symptoms in patients with schizophreniaMental Health - SchizophreniaACTRN12608000461392niversity of New South Wales80